Hologic Inc at Raymond James Institutional Investors Conference Transcript
Good morning. Welcome to day 2 of the Raymond James Institutional Investor Conference. I'm Andrew Cooper. I cover diagnostics here at Raymond James. We're excited to have Hologic joining us this morning, so a company that you've probably heard the name of for COVID. If you hadn't prior, but there's a heck of a lot more to the story. We're going to get into that.
I'm joined by CFO, Karleen Oberton, for a fireside chat; as well as Ryan Simon, who heads up the IR efforts. So maybe just to start, if you don't mind, for some folks maybe newer to the story, can you give us a little bit of a quick intro to who Hologic is, what you do, some of the markets you play in, and just sort of an overview in general?
Sure. Absolutely, and thank you, Andrew, for having us today, where it's a pleasure to be here. It's certainly a pleasure to be here in person, first in-person conference in 2 years, so this is really special.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
